Up-regulation of MAP17 expression increases proliferative capabilities, decreases apoptotic sensitivity and improves migration ability of the tumor cells via increasing the level of reactive oxygen species (ROS) [12, 14]. The gene discussed is PDZK1IP1; the disease is neoplasm.